THE ADCT RESOURCES ARE AVAILABLE IN 50 VALIDATED TRANSLATIONS
Please select your preferred language from the list of validated translations below. Note: The ADCT questionnaire
should be answered in your native language.
If your preferred language is unavailable, reach out to MAPI Research Trust to submit a request here. Please do not translate the tool yourself.
Pediatric and Caregiver versions of the ADCT will soon be available for download
Overview of available ADCT materials
ADCT patient form
The ADCT patient form provides an easy means of completing ADCT and evaluating
total ADCT score in clinical practice.
This questionnaire is suitable for self-directed use by patients to complete ADCT
and evaluate their total ADCT score. The six brief questions can be easily
completed at home or during a routine consultation.
Patients may benefit from guidance around scoring ADCT prior to using ADCT for
the first time.
ADCT was developed to facilitate patient-physician discussion on
control of atopic dermatitis. ADCT is not intended to replace the
physician’s medical judgment in diagnosing and treating the patient.
ADCT HCP information card
The ADCT HCP information card provides you with a short summary of ADCT, its
development and validation process as well as some general recommendations for
the interpretation of the ADCT total score in daily practice, based on
validation and longitudinal studies.
Terms and conditions – consent
ADCT terms of use
Atopic Dermatitis Control Tool (ADCT) has been scientifically validated to assess atopic dermatitis control status in adult and adolescent patients (12 years and older). To use ADCT correctly, a patient must answer all six ADCT questions by selecting the most appropriate answer. Patients should use ADCT in their own language.
ADCT was developed to facilitate patient-physician discussion on control of atopic dermatitis. ADCT is not intended to replace the physician’s medical judgment in diagnosing and treating the patient.
The user acknowledges and accepts that they are not entitled to amend, modify, condense, adapt, reorganise the tool on any medium whatsoever, in any way whatsoever, even minor, without Sanofi Genzyme’s and Regeneron’s prior specific written consent.
Use in individual clinical practice:
Users must ensure that ADCT is used in the context and with the standards it has been designed and validated for.
Use in scientific studies, clinical trials or research projects:
You will be asked to complete a request form describing the intended use of the tool. The information provided with this form helps to ensure that ADCT is used in the context and with the standards it has been designed and validated for.